Prospective comparative study on etiologic diagnosis of ventilator-associated pneumonia.
R. Melo (Uberlândia, Brazil), M. Gomes (Uberlândia, Brazil), V. Oliveira (Uberlândia, Brazil), D. Scheucher (Uberlândia, Brazil), R. Silva (Uberlândia, Brazil), L. Goulart Filho (Uberlândia, Brazil), D. Brito (Uberlândia, Brazil), T. Cunha (Uberlândia, Brazil)
Source: International Congress 2018 – Epidemiology and prognostication of critically-ill patients
Disease area: Respiratory critical care
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Melo (Uberlândia, Brazil), M. Gomes (Uberlândia, Brazil), V. Oliveira (Uberlândia, Brazil), D. Scheucher (Uberlândia, Brazil), R. Silva (Uberlândia, Brazil), L. Goulart Filho (Uberlândia, Brazil), D. Brito (Uberlândia, Brazil), T. Cunha (Uberlândia, Brazil). Prospective comparative study on etiologic diagnosis of ventilator-associated pneumonia.. 318
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Comparative study of clinical diagnostic criteria for ventilator-associated pneumonia Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010
Community-acquired pneumonia. Prospective inpatient study Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004
Prospective evaluation of clinical and microbiological parameters in patients with community-acquired pneumonia with and without comorbidity Source: Eur Respir J 2006; 28: Suppl. 50, 530s Year: 2006
Epidemiology and outcomes in hospitalized patients with health-care-associated pneumonia (HCAP) and community-acquired pneummonia (CAP)~ A prospective observational cohort analysis Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study. Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018
Etiology of community-acquired pneumonia requiring hospitalization in Chile: a prospective study Source: Eur Respir J 2005; 26: Suppl. 49, 255s Year: 2005
Community-acquired pneumonia in the elderly: Spanish multicentre study Source: Eur Respir J 2003; 21: 294-302 Year: 2003
Management of community-acquired pneumonia in primary care: an observational study Source: International Congress 2019 – Treatment of airway diseases in primary care Year: 2019
The impact of hyperglycemia on community-acquired pneumonia: A retrospective cohort study Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
New evidence of risk factors for community-acquired pneumonia: a population-based study Source: Eur Respir J 2008; 31: 1274-1284 Year: 2008
The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia Year: 2007
Etiology of community-acquired pneumonia: an autopsy study Source: Annual Congress 2006 - Miscellaneous respiratory infections I Year: 2006
Bacteriological diagnosis in hospitalized community-acquired pneumonia (HCAP): an eighteen-month study Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001
Clinical stability predictors and length of stay in adults with community-acquired pneumonia. Prospective cohort Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015
Ventilator-associated pneumonia (VAP): epidemiology, empirical treatment and outcome Source: Eur Respir J 2005; 26: Suppl. 49, 188s Year: 2005
Risk factors for community-acquired pneumonia in hospitalized adult patients, a case-control study Source: Eur Respir J 2006; 28: Suppl. 50, 351s Year: 2006
Association between biomarkers at discharge and risk of readmission after community-acquired pneumonia – a retrospective cohort study Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis Year: 2017
Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study Source: Eur Respir J 2009; 34: 1364-1375 Year: 2009
New approaches to the aetiological diagnosis of VAP Source: Eur Respir Mon 2011; 53: 11-23 Year: 2011
Do not resuscitat orders in community-acquired pneumonia: a restrospective cohort study. Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017